Acute Myocardial Infarction (AMI): Clinical Trials

5 trials for Acute Myocardial Infarction (AMI), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 active not recruiting. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 2, Recruiting 2, Active not recruiting 1

Follow Acute Myocardial Infarction (AMI): new trials by email Literature Review of Acute Myocardial Infarction (AMI) trials Research Report on Acute Myocardial Infarction (AMI)

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction
Zastaprazan, Proton Pump Inhibitors (PPI) - Acute Myocardial Infarction (AMI), Gastrointestinal Bleeding
Phase 3RecruitingSamsung Medical Center50002026-06-232026-06-26
Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction
Ziltivekimab, Placebo - Coronary Artery Disease, Acute Myocardial Infarction (AMI)
Phase 3RecruitingECRI bv3322025-12-192026-03-23
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Ziltivekimab, Placebo - Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3Active not recruitingNovo Nordisk A/S100002024-06-252026-09-09
Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers
Oxygen - Acute Myocardial Infarction (AMI), Acute Coronary Syndrome (ACS)
Phase 3CompletedKarolinska Institutet1752014-10-012017-12-11
AngelMed for Early Recognition and Treatment of STEMI
Guardian System - Acute Myocardial Infarction (AMI), Coronary Occlusion
Phase 3CompletedAngel Medical Systems10202008-12-012018-03-14

Narrower conditions

Acute Coronary Syndrome (2)  ·  Angina, Unstable (1)  ·  Atherosclerosis (1)  ·  Coronary Artery Disease (1)  ·  Coronary Occlusion (1)  ·  Gastrointestinal Hemorrhage (1)  ·  Myocardial Infarction (1)  ·  Non-ST Elevated Myocardial Infarction (1)  ·  ST Elevation Myocardial Infarction (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Myocardial Ischemia (3)  ·  Vascular Diseases (3)  ·  Coronary Disease (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Angina Pectoris (1)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Chest Pain (1)  ·  Digestive System Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Hemorrhage (1)  ·  Infarction (1)

Interventions

ziltivekimab (2)  ·  Oxygen (1)  ·  Proton Pump Inhibitors (1)

Sponsors

Angel Medical Systems (1)  ·  ECRI bv (1)  ·  Karolinska Institutet (1)  ·  Novo Nordisk A/S (1)  ·  Samsung Medical Center (1)

Countries

South Korea (2)  ·  United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  India (1)  ·  Israel (1)

Top investigators

Ernest Spitzer, MD (1)  ·  Lennart Lennart, MD, PHD (1)

Results publications

PMID 24576515, PMID 25066555, PMID 27436882, PMID 29226465, PMID 30842028, PMID 31081342, PMID 31623762

NIH funding

2023 (1)